Is donepezil (Aricept) safe for long-term use and analysis of precautions

1. Drug Overview and Mechanism of Action

Donepezil (trade name Aricept®) is a reversible acetylcholinesterase inhibitor (AChEI), mainly used to treat mild to moderate Alzheimer's disease (AD) and other types of cognitive impairment. Its mechanism of action is by inhibiting the activity of acetylcholinesterase and increasing the concentration of acetylcholine in the brain, thereby improving nerve signal transmission and cognitive function. Compared with other acetylcholinesterase inhibitors, donepezil has the advantages of oral convenience, once-daily administration, and long drug half-life, making it one of the most commonly used clinical drugs for the treatment of AD.

2. The efficacy and safety of long-term use

Donepezil has been widely used for the long-term treatment of patients with Alzheimer's disease. Clinical studies have shown that long-term use of donepezil can stabilize or delay the decline of cognitive function and improve daily living abilities and behavioral symptoms. For example, in patients who took donepezil continuously for 6 months to 3 years, the decline in cognitive scores (such as MMSE or ADAS-Cog) was significantly slowed down, and some patients even maintained a relatively stable cognitive state.

In terms of safety, donepezil was generally well tolerated. The most common adverse reactions include gastrointestinal symptoms (nausea, vomiting, diarrhea), insomnia, headache, fatigue etc. Most of them are mild to moderate and can be gradually alleviated with dose adjustment or adaptation period. Serious adverse reactions are relatively rare, but attention should still be paid to abnormal heart rhythms (such as slow heart rate, atrioventricular block) and rare liver function abnormalities. Long-term studies have shown that donepezil does not significantly increase the risk of renal or liver damage, but patients with cardiovascular disease need to be particularly cautious.

3. Precautions for long-term use

1.Dose management: The initial dose is usually 5mg once a day, which can be increased to 10mg once a day after 4 to 6 weeks based on tolerance. For elderly patients or those with reduced liver and kidney function, the dose adjustment period can be appropriately extended. Increasing the dose too quickly may cause gastrointestinal discomfort or slowed heart rate.

2.Cardiovascular monitoring: donepezil can cause mild bradycardia, therefore Patients with heart disease, atrioventricular block and hypotension need to undergo an electrocardiogram before long-term use and review regularly during treatment.

3.Drug interactions: Donepezil metabolism mainly depends on the liver CYP2D6 and CYP3A4 enzyme systems. When using inhibitors (such as fluconazole, erythromycin) or inducers (such as rifampicin) of these enzymes in combination, it is necessary to pay attention to changes in drug blood concentrations and adjust the dosage.

4.Nutrition and lifestyle habits: Patients who take donepezil for a long time, especially the elderly, should maintain a regular diet, sufficient fluids and moderate exercise to avoid dehydration, constipation or weight loss caused by the drug.

4. Clinical management strategies for long-term use

Long-term use of donepezil not only relies on the efficacy of the drug itself, but also requires combination regular cognitive assessment, behavioral symptom monitoring and family support. Clinical recommendations:

1.Regular review of cognitive function: MMSE or ADAS-Cog score every 3-6 months to evaluate the efficacy of the drug and adjust the treatment plan.

2.Monitor adverse reactions: pay special attention to gastrointestinal symptoms, heart rate changes and sleep conditions. If serious side effects occur, they can be alleviated by adjusting the dose or taking it in divided doses.

3.Combined intervention: Donepezil can be combined with cognitive training, psychological intervention and lifestyle improvement to enhance the efficacy and improve the patient's quality of life.

4.Attention to special groups: Patients with liver and kidney dysfunction, cardiovascular disease, and those taking multiple drugs need to adjust the plan individually and use it under the guidance of a professional doctor.

5. Comprehensive evaluation

To sum up, donepezil is generally safe and reliable in long-term use. It can effectively delay the decline of cognitive function in Alzheimer's disease and also has a certain effect on improving daily life ability and behavioral symptoms. Despite potential side effects such as gastrointestinal discomfort and slowed heart rate, most patients can safely tolerate it with reasonable dose adjustment, regular monitoring and comprehensive management. Long-term use of donepezil should be combined with clinical assessment, family support, and lifestyle intervention to achieve optimal treatment effects while minimizing risks.

Reference link:https://www.drugs.com